Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (271-280 of 334) with videos related to

Pageof 34
Sort By:
Nature Communications|August 19, 2020
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in miceRouven Hoefflin, Sabine Harlander, Silvia Schäfer, et al.
Bone Marrow Transplantation|October 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTPatryk Sobieralski, Tomasz Czerw, Luuk Gras, et al.
Haematologica|July 3, 2025
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia ReportPedro Henrique Prata, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Signal Transduction and Targeted Therapy|December 10, 2025
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignanciesMichael Rassner, Tony Andreas Müller, Kirstyn Anne Crossley, et al.
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Blood|March 5, 2016
BRAF inhibition in hairy cell leukemia with low-dose vemurafenibSascha Dietrich, Andreas Pircher, Volker Endris, et al.
Bone Marrow Transplantation|November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTKavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Nature|August 2, 2019
Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasionAnna M Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
Blood|January 9, 2026
Gastrin for the treatment of acute graft-versus-host disease of the stomachJana Gawron, Marie Czech, Tamina Rückert, et al.
Pageof 34

Showing results (271-280 of 334) with videos related to

Sort By:
Pageof 34
Nature Communications|August 19, 2020
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in miceRouven Hoefflin, Sabine Harlander, Silvia Schäfer, et al.
Bone Marrow Transplantation|October 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTPatryk Sobieralski, Tomasz Czerw, Luuk Gras, et al.
Haematologica|July 3, 2025
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia ReportPedro Henrique Prata, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Signal Transduction and Targeted Therapy|December 10, 2025
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignanciesMichael Rassner, Tony Andreas Müller, Kirstyn Anne Crossley, et al.
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Blood|March 5, 2016
BRAF inhibition in hairy cell leukemia with low-dose vemurafenibSascha Dietrich, Andreas Pircher, Volker Endris, et al.
Bone Marrow Transplantation|November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTKavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Nature|August 2, 2019
Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasionAnna M Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
Blood|January 9, 2026
Gastrin for the treatment of acute graft-versus-host disease of the stomachJana Gawron, Marie Czech, Tamina Rückert, et al.
Pageof 34